RedHill Biopharma reported $4.27M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Cara Therapeutics USD 20.95M 6.92M Dec/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
Cronos Group USD 1.07B 20.24M Mar/2026
RedHill Biopharma USD 4.27M 8.68M Dec/2025